These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 17576043

  • 1. Postmenopausal HRT and tibolone in relation to muscle strength and body composition.
    Jacobsen DE, Samson MM, Kezic S, Verhaar HJ.
    Maturitas; 2007 Sep 20; 58(1):7-18. PubMed ID: 17576043
    [Abstract] [Full Text] [Related]

  • 2. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY.
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct 20; 31(6):541-9. PubMed ID: 12407324
    [Abstract] [Full Text] [Related]

  • 3. Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study.
    Boyanov MA, Shinkov AD.
    Maturitas; 2005 Aug 16; 51(4):363-9. PubMed ID: 16039409
    [Abstract] [Full Text] [Related]

  • 4. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.
    Menopause; 2006 Aug 16; 13(4):660-8. PubMed ID: 16837888
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S, Moaya M, Faghihzadeh S.
    Climacteric; 2010 Jun 16; 13(3):249-53. PubMed ID: 19848555
    [Abstract] [Full Text] [Related]

  • 6. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 7. Muscle strength and tibolone: a randomised, double-blind, placebo-controlled trial.
    Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ.
    BJOG; 2002 Jan 15; 109(1):77-84. PubMed ID: 11845814
    [Abstract] [Full Text] [Related]

  • 8. Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial.
    Jacobsen DE, Melis RJ, Verhaar HJ, Olde Rikkert MG.
    J Am Med Dir Assoc; 2012 Feb 15; 13(2):189.e1-7. PubMed ID: 21741883
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.
    Jensen LB, Vestergaard P, Hermann AP, Gram J, Eiken P, Abrahamsen B, Brot C, Kolthoff N, Sørensen OH, Beck-Nielsen H, Nielsen SP, Charles P, Mosekilde L.
    J Bone Miner Res; 2003 Feb 15; 18(2):333-42. PubMed ID: 12568411
    [Abstract] [Full Text] [Related]

  • 10. Low-dose tibolone (1.25 mg/d) does not affect muscle strength in older women.
    Ribom EL, Svensson P, van Os S, Larsson M, Naessen T.
    Menopause; 2011 Feb 15; 18(2):194-7. PubMed ID: 20689464
    [Abstract] [Full Text] [Related]

  • 11. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
    Sørensen MB, Rosenfalck AM, Højgaard L, Ottesen B.
    Obes Res; 2001 Oct 15; 9(10):622-6. PubMed ID: 11595778
    [Abstract] [Full Text] [Related]

  • 12. Resistance training in postmenopausal women with and without hormone therapy.
    Teixeira PJ, Going SB, Houtkooper LB, Metcalfe LL, Blew RM, Flint-Wagner HG, Cussler EC, Sardinha LB, Lohman TG.
    Med Sci Sports Exerc; 2003 Apr 15; 35(4):555-62. PubMed ID: 12673136
    [Abstract] [Full Text] [Related]

  • 13. HRT provides no additional beneficial effect on sarcopenia in physically active postmenopausal women: a cross-sectional, observational study.
    Aubertin-Leheudre M, Audet M, Goulet ED, Dionne IJ.
    Maturitas; 2005 Jun 16; 51(2):140-5. PubMed ID: 15917154
    [Abstract] [Full Text] [Related]

  • 14. Tibolone does not affect muscle power and functional ability in healthy postmenopausal women.
    Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ.
    Clin Sci (Lond); 2002 Feb 16; 102(2):135-41. PubMed ID: 11834133
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of hormone replacement therapy on insulin resistance and platelet function tests.
    Saraç F, Saydam G, Sahin F, Oztekin K, Saygili F, Tüzün M, Yilmaz C.
    Med Princ Pract; 2009 Feb 16; 18(1):43-7. PubMed ID: 19060490
    [Abstract] [Full Text] [Related]

  • 17. Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation.
    Törmälä RM, Appt S, Clarkson TB, Tikkanen MJ, Ylikorkala O, Mikkola TS.
    Climacteric; 2007 Dec 16; 10(6):471-9. PubMed ID: 18049940
    [Abstract] [Full Text] [Related]

  • 18. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE.
    Climacteric; 2001 Dec 16; 4(4):314-9. PubMed ID: 11770188
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator.
    Campisi R, Marengo FD.
    Cardiovasc Drug Rev; 2007 Dec 16; 25(2):132-45. PubMed ID: 17614936
    [Abstract] [Full Text] [Related]

  • 20. Association between bone, body composition and strength in premenarcheal girls and postmenopausal women.
    van Langendonck L, Claessens AL, Lysens R, Koninckx PR, Beunen G.
    Ann Hum Biol; 2004 Dec 16; 31(2):228-44. PubMed ID: 15204365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.